John G. Watkin, DPhil | Psychiatrist.com

Original Research

Duloxetine in the Treatment of Major Depressive Disorder: Comparisons of Safety and Efficacy in U.S. Hispanic and Majority Caucasian Patients

September 15, 2006

Roberto Lewis-Fernández, Carlos Blanco, Craig H. Mallinckrodt, et al

Original Research

Duloxetine Efficacy for Major Depressive Disorder in Male vs. Female Patients: Data From 7 Randomized, Double-Blind, Placebo-Controlled Trials

May 15, 2006

Susan G. Kornstein, Madelaine M. Wohlreich, Craig H. Mallinckrodt, et al

Original Research

Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder

June 15, 2005

Pedro L. Delgado, Stephen K. Brannan, Craig H. Mallinckrodt, et al

Letter to the Editor

Duloxetine's Role in the Treatment of Depression and Associated Painful Physical Symptoms

July 1, 2004

Madelaine M. Wohlreich, John G. Watkin, Jill S. Gonzales

Original Research

The Effect of Duloxetine on Painful Physical Symptoms in Depressed Patients: Do Improvements in These Symptoms Result in Higher Remission Rates?

April 1, 2004

Maurizio Fava, Craig H. Mallinckrodt, Michael J. Detke, et al

Letter to the Editor

The Role of Duloxetine in the Treatment of Depression and Associated Painful Physical Symptoms

December 1, 2003

Madelaine M. Wohlreich, John G. Watkin

Original Research

Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression

February 1, 2003

Craig H. Mallinckrodt, David J. Goldstein, Michael J. Detke, et al